anchor instance (Q118460)

From ScienceSource
Revision as of 09:29, 17 April 2019 by Charles Matthews (talk | contribs) (‎Created a new item)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
No description defined
Language Label Description Also known as
English
anchor instance
No description defined

    Statements

    the Food and Drug Administration (FDA) for chronic management of obese adults: orlistat, locaserin,
    0 references
    /topiramate (extended release) and naltrexone/bupropion (extended release) [[6]]. Of these, orlistat
    0 references
    21
    0 references
    103
    0 references
    4,662
    0 references
    17 April 2019
    0 references
    0 references
    Marine Algae as a Potential Source for Anti-Obesity Agents (5192459)
    0 references